Related Experiment Videos
Minimally invasive therapy: the French case study
1National School of Public Health, Rennes, France.
Health Policy (Amsterdam, Netherlands)
|December 9, 1992
Summary
Minimally invasive surgery adoption in France varies by technology. Factors influencing diffusion include regulatory gaps, institutional constraints, physician autonomy, and media influence.
Area of Science:
- Health Services Research
- Medical Technology Assessment
- Health Policy
Background:
- The adoption of new medical technologies, particularly in minimally invasive surgery (MIS), presents diverse diffusion patterns within healthcare systems.
- Understanding the factors influencing the uptake of innovations like arthroscopy, lithotripsy, and laparoscopic cholecystectomy is crucial for effective healthcare management.
Purpose of the Study:
- To analyze the varying diffusion rates of 10 selected minimally invasive surgical technologies in France.
- To identify common characteristics and influencing factors in the dissemination of medical innovations within the French healthcare system since the 1980s.
Main Methods:
- Comparative analysis of the diffusion of 10 distinct minimally invasive surgical technologies in France.
- Qualitative assessment of systemic factors impacting technology adoption, including regulatory, organizational, financial, judicial, professional, industrial, and media influences.
Main Results:
- Diffusion rates for selected MIS technologies in France range from widely established (arthroscopy, lithotripsy) to rapidly adopting (laparoscopic cholecystectomy) and narrowly used (laser-based technologies).
- Key systemic factors influencing innovation diffusion include: limited health authority control over medical innovation, financial and organizational constraints on healthcare institutions, weak judicial oversight, significant physician autonomy in adopting innovations, a less robust domestic medical industry, and a substantial media impact.
Conclusions:
- A uniform model for minimally invasive surgery diffusion in France is not feasible due to technological heterogeneity.
- The French healthcare system exhibits specific patterns in medical innovation diffusion, shaped by a complex interplay of regulatory, economic, professional, and media-related elements.